440 related articles for article (PubMed ID: 18677409)
1. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
Osei-Hyiaman D; Liu J; Zhou L; Godlewski G; Harvey-White J; Jeong WI; Bátkai S; Marsicano G; Lutz B; Buettner C; Kunos G
J Clin Invest; 2008 Sep; 118(9):3160-9. PubMed ID: 18677409
[TBL] [Abstract][Full Text] [Related]
2. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
[TBL] [Abstract][Full Text] [Related]
3. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
[TBL] [Abstract][Full Text] [Related]
4. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
Bartelt A; Orlando P; Mele C; Ligresti A; Toedter K; Scheja L; Heeren J; Di Marzo V
Diabetologia; 2011 Nov; 54(11):2900-10. PubMed ID: 21847582
[TBL] [Abstract][Full Text] [Related]
5. CB
Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
Elife; 2020 Nov; 9():. PubMed ID: 33210603
[TBL] [Abstract][Full Text] [Related]
6. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB
Yoshida K; Kita Y; Tokuoka SM; Hamano F; Yamazaki M; Sakimura K; Kano M; Shimizu T
FASEB J; 2019 Feb; 33(2):2484-2497. PubMed ID: 30265576
[TBL] [Abstract][Full Text] [Related]
7. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between diet-induced steatosis and onset of insulin/leptin resistance in male Wistar rats.
Zhang L; Song H; Ge Y; Ji G; Yao Z
PLoS One; 2015; 10(2):e0117008. PubMed ID: 25658428
[TBL] [Abstract][Full Text] [Related]
10. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice.
Jourdan T; Djaouti L; Demizieux L; Gresti J; Vergès B; Degrace P
Diabetes; 2010 Apr; 59(4):926-34. PubMed ID: 20110567
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.
Osei-Hyiaman D; DePetrillo M; Pacher P; Liu J; Radaeva S; Bátkai S; Harvey-White J; Mackie K; Offertáler L; Wang L; Kunos G
J Clin Invest; 2005 May; 115(5):1298-305. PubMed ID: 15864349
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
14. Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats.
Almeida MM; Dias-Rocha CP; Reis-Gomes CF; Wang H; Atella GC; Cordeiro A; Pazos-Moura CC; Joss-Moore L; Trevenzoli IH
Psychoneuroendocrinology; 2019 May; 103():306-315. PubMed ID: 30776574
[TBL] [Abstract][Full Text] [Related]
15. Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes.
Ruby MA; Nomura DK; Hudak CS; Barber A; Casida JE; Krauss RM
PLoS One; 2011; 6(11):e26415. PubMed ID: 22073164
[TBL] [Abstract][Full Text] [Related]
16. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
17. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
18. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant.
Chen HJ; Liu J
Biomed Pharmacother; 2018 Jan; 97():1386-1396. PubMed ID: 29156528
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.
Liu J; Zhou L; Xiong K; Godlewski G; Mukhopadhyay B; Tam J; Yin S; Gao P; Shan X; Pickel J; Bataller R; O'Hare J; Scherer T; Buettner C; Kunos G
Gastroenterology; 2012 May; 142(5):1218-1228.e1. PubMed ID: 22307032
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
